GR

Girish Ranchhodbhai Patel

Active Director Additional Director DIN 10951234
DIN 10951234 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Girish Ranchhodbhai Patel

Data last updated:

Girish Ranchhodbhai Patel is an Additional Director at Sharda Medical Agency Private Limited (since 2025). The company operates in Pharma.

DIN 10951234
Primary Designation Additional Director
Industry Pharma
First Appointment 01 Feb 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director01 Feb 20252024Active

Board colleagues of Girish Ranchhodbhai Patel

Directorship timeline

Open interactive timeline →
Sharda Medical Agency Private Limited
Premium access

Shareholding and investment profile for Girish Ranchhodbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish Ranchhodbhai Patel

Girish Ranchhodbhai Patel currently holds 1 directorship: Sharda Medical Agency Private Limited (Additional Director, since 01 Feb 2025).

Girish Ranchhodbhai Patel was first appointed on 01 Feb 2025 as Additional Director at Sharda Medical Agency Private Limited.

The current boards of Girish Ranchhodbhai Patel's companies include Ravi Ashok Mishra (Sharda Medical Agency Private Limited), Ravi Girishbhai Patel (Sharda Medical Agency Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available